Satsuma Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Satsuma Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 2.55 million shares as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2023-05-11
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.55M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.24M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 2.08M shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.78M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2023-03-31 | 2.55M shares 10-Q · filed 2023-05-11 |
| 2022-09-30 | 2.24M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 2.08M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 1.78M shares 10-Q · filed 2022-05-10 |
| 2019-09-30 | 341.10K shares 10-Q · filed 2019-11-12 |